Nara, Japan

Hitoshi Niwa

This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Niwa. Retrieved from https://idiyas.com/inventor/hitoshi-niwa-5idvzec3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hitoshi Niwa: Innovator in Stem Cell Research

Introduction

Hitoshi Niwa is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of stem cell research, particularly in the cultivation of pluripotent stem cells. His innovative work has the potential to advance medical research and therapeutic applications.

Latest Patents

Hitoshi Niwa holds a patent for a "Composition for culturing mouse pluripotent stem cells." This invention aims to proliferate or establish undifferentiated pluripotent stem cells that retain their differentiation potency. The method involves culturing pluripotent stem cells in a medium free of feeder cells or serum. The culture medium is supplemented with an inhibitor of adenylate cyclase activity, which enhances the growth and maintenance of these vital cells.

Career Highlights

Niwa is associated with Riken Corporation, a leading research institution in Japan. His work at Riken has focused on developing methods to improve the efficiency of stem cell culture, which is crucial for various applications in regenerative medicine and developmental biology.

Collaborations

Hitoshi Niwa has collaborated with Kazuya Ogawa, contributing to advancements in their shared field of research. Their partnership has fostered innovative approaches to stem cell technology.

Conclusion

Hitoshi Niwa's contributions to stem cell research exemplify the impact of innovative thinking in science. His patent and ongoing work continue to influence the future of regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…